n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Crush Syndrome in 1 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haruta, Y | 1 |
| Kobayakawa, K | 1 |
| Saiwai, H | 1 |
| Hata, K | 1 |
| Tamaru, T | 1 |
| Iura, H | 1 |
| Ono, G | 1 |
| Kitade, K | 1 |
| Kijima, K | 1 |
| Iida, K | 1 |
| Kawaguchi, K | 1 |
| Matsumoto, Y | 1 |
| Kubota, K | 1 |
| Maeda, T | 1 |
| Konno, DJ | 1 |
| Okada, S | 1 |
| Nakashima, Y | 1 |
1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Crush Syndrome
| Article | Year |
|---|---|
Zinc chelator treatment in crush syndrome model mice attenuates ischemia-reperfusion-induced muscle injury due to suppressing of neutrophil infiltration.
Topics: Animals; Anti-Inflammatory Agents; Chelating Agents; Chemokines; Crush Syndrome; Cytokines; Ethylene | 2022 |